A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Part of paid clinical trials in Bellflower, California.
- Sponsor
- Indiana University
- Study ID
- NCT02008773
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Not accepted
Interventions
- Valacyclovir HCI 500 mg tablets — DRUGValacyclovir HCI 500 mg capsules 6/day oral for 16 weeks
- placebo — DRUGplacebo capsules 6/day oral for 16 weeks
Study Details
The primary aim of the study is to determine the efficacy of adjunctive valacyclovir, in comparison to placebo, to improve visual (Brief Visuospatial Memory Test) and working (composite score of the Spatial Span and Letter Number Span tests) memory in individuals who are HSV-1 positive and early in the course of schizophrenia. We hypothesize that individuals who are HSV-1 positive, but not those who are HSV-1 negative, will demonstrate significant valacyclovir efficacy for visual and working memory.
Key Dates
- Start date
- Mar 26, 2014
- Status verified
- Jan 2019
- Primary completion
- Jun 20, 2017
- Completion
- Jun 20, 2017
Study Design
- Enrollment
- 170 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: valacyclovir3000mg daily oral 16 weeks
- Placebo Comparator: placeboplacebo 6 capsules daily oral 16 weeks
Primary Outcome Measure
Visual Memory [ Time Frame: Baseline, 8 weeks, and 16 weeks ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| C.I. Trials, Inc.-Los Angeles County | Bellflower | California | 90706 | - |
| University of California, Los Angeles | Los Angeles | California | 90095 | - |
| University of California, Riverside at C.I. Trials, Inc.-Inland Empire | Riverside | California | 92506 | - |
| C.I. Trials, Inc.-Orange County | Santa Ana | California | 92705 | - |
| Yale University | New Haven | Connecticut | 06519 | - |
| Innovative Clinical Research, Inc. | Lauderhill | Florida | 33319 | - |
| Indiana University Psychotic Disorders Clinic | Indianapolis | Indiana | 46222 | - |
| Prevention and Recovery Center for Early Psychosis | Indianapolis | Indiana | 46202 | - |
| University of Kansas Medical Center-Witchita | Wichita | Kansas | 67214 | - |
| Maryland Psychiatric Research Center | Baltimore | Maryland | 21228 | - |
| Centers for Behavioral Health, LLC | Rockville | Maryland | 20850 | - |
| Sheppard Pratt Health System | Towson | Maryland | 21204 | - |
| Laureate Institute for Brain Research | Tulsa | Oklahoma | 74136 | - |
Find similar trials in Bellflower, CA
By condition
By specialty
By research site
C.I. Trials, Inc.-Los Angeles County· Bellflower, CAUniversity of California, Los Angeles· Los Angeles, CAUniversity of California, Riverside at C.I. Trials, Inc.-Inland Empire· Riverside, CAC.I. Trials, Inc.-Orange County· Santa Ana, CAYale University· New Haven, CTInnovative Clinical Research, Inc.· Lauderhill, FL
Related Studies
- Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) ScanningRecruiting · Yale University · New Haven, Connecticut
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaPHASE3 · Recruiting · Gedeon Richter Plc. · Culver City, California
- Imaging Synapses With [11C] UCB-J in the Human BrainPHASE1 · Recruiting · Davidzon, Guido, M.D. · Palo Alto, California
- Synbiotic Compound to Reduce Symptoms of SchizophreniaPHASE2 · Recruiting · Sheppard Pratt Health System · Batlimore, Maryland